Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours

British Journal of Cancer

Volumn 94, Issue 9, 2006, Pages 1231-1232

  Ackers, C ^a,b   Rustin, G J S ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Germ cell tumours; LDH; Relapse; Surveillance

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; LACTATE DEHYDROGENASE;

ARTICLE; CANCER RELAPSE; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PATIENT MONITORING; PRIORITY JOURNAL; SEMINOMA;

HUMANS; L-LACTATE DEHYDROGENASE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROSPECTIVE STUDIES; SEMINOMA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33646499466     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603087     Document Type: Article

References (6)

1. Group IGCU (1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15(2): 594-603
2. Lippert MC, Javadpour N (1981) Lactate dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer 48(10): 2274-2278
3. Morris MJ, Bosl GJ (2000) Recognising abnormal marker results that do not reflect disease in patients with germ cell tumours. J Urol 164(5): 1670
4. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB, Cook PA (1992) Medical Research Council Prospective Study of Surveillance for Stage I testicular teratoma. J Clin Oncol 10(11): 1762-1768
5. Trigo JM, Tabernero JM, Paz-Aresh L, Mira J (2000) Tumour markers at the time of recurrence in patients with germ cell tumours. Cancer 88(1): 162-168
6. Von Eyben FE (2001) A systematic review of LDH isoenzyme 1 and germ cell tumours. Clin Biochem 34(6): 441-454